UroGen Pharma (URGN) Assets (2016 - 2026)
UroGen Pharma (URGN) posted Assets of $252.59 million for Q2 2026, up 21.0% from $208.72 million a year earlier but down 0.4% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Assets came in at $200.46 million, down 29.8% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
- In prior years, UroGen Pharma's Assets was $285.71 million in FY2024 (+60.2%), $178.31 million in FY2023 (+31.5%), $135.62 million in FY2022 (+13.3%) and $119.75 million in FY2021 (-1.9%).
- Quarterly Assets has run from a low of $95.36 million in Q2 2023 to a high of $301.94 million in Q3 2024 over five years.
- On a year-over-year basis, Assets increased in five of the last eight quarters, with growth averaging 8.6%.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2024, with growth of 195.6%; the weakest was Q3 2025, with a decline of 38.7%.
- According to Business Quant data, Assets for the three prior quarters was $253.69 million (Q1 2026), $200.46 million (Q4 2025) and $185.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | UroGen Pharma | 1.99 Bn | 1.49 Bn | 65.88 Mn | 252.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.59 Mn |
| Mar 31, 2026 | 253.69 Mn |
| Dec 31, 2025 | 200.46 Mn |
| Sep 30, 2025 | 185.05 Mn |
| Jun 30, 2025 | 208.72 Mn |
| Mar 31, 2025 | 247.62 Mn |
| Dec 31, 2024 | 285.71 Mn |
| Sep 30, 2024 | 301.94 Mn |
| Jun 30, 2024 | 281.85 Mn |
| Mar 31, 2024 | 200.57 Mn |
| Dec 31, 2023 | 178.31 Mn |
| Sep 30, 2023 | 193.63 Mn |
| Jun 30, 2023 | 95.36 Mn |
| Mar 31, 2023 | 112.95 Mn |
| Dec 31, 2022 | 135.62 Mn |
| Sep 30, 2022 | 128.47 Mn |
| Jun 30, 2022 | 146.14 Mn |
| Mar 31, 2022 | 165.72 Mn |
| Dec 31, 2021 | 119.75 Mn |
| Sep 30, 2021 | 134.60 Mn |
API Access
UroGen Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();